Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

Antibiotic susceptibility of probiotic strains: Is it reasonable to combine probiotics with antibiotics?

Neut C, Mahieux S, Dubreuil LJ.

Med Mal Infect. 2017 Nov;47(7):477-483. doi: 10.1016/j.medmal.2017.07.001. Epub 2017 Aug 7.

PMID:
28797834
2.

nimH, a novel nitroimidazole resistance gene contributing to metronidazole resistance in Bacteroides fragilis.

Alauzet C, Berger S, Jean-Pierre H, Dubreuil L, Jumas-Bilak E, Lozniewski A, Marchandin H.

J Antimicrob Chemother. 2017 Sep 1;72(9):2673-2675. doi: 10.1093/jac/dkx160. No abstract available.

PMID:
28535278
3.

The development of plant food processing in the Levant: insights from use-wear analysis of Early Epipalaeolithic ground stone tools.

Dubreuil L, Nadel D.

Philos Trans R Soc Lond B Biol Sci. 2015 Nov 19;370(1682). pii: 20140357. doi: 10.1098/rstb.2014.0357.

4.

Controlled delivery of a new broad spectrum antibacterial agent against colitis: In vitro and in vivo performance.

Nieto-Bobadilla MS, Siepmann F, Djouina M, Dubuquoy L, Tesse N, Willart JF, Dubreuil L, Siepmann J, Neut C.

Eur J Pharm Biopharm. 2015 Oct;96:152-61. doi: 10.1016/j.ejpb.2015.07.012. Epub 2015 Jul 21.

PMID:
26209123
5.

Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.

Brown D, Canton R, Dubreuil L, Gatermann S, Giske C, MacGowan A, Martinez-Martinez L, Mouton J, Skov R, Steinbakk M, Walton C, Heuer O, Struelens MJ, Diaz Hogberg L, Kahlmeter G.

Euro Surveill. 2015 Jan 15;20(2). pii: 21008.

6.

In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.

Karrout Y, Dubuquoy L, Piveteau C, Siepmann F, Moussa E, Wils D, Beghyn T, Neut C, Flament MP, Guerin-Deremaux L, Dubreuil L, Deprez B, Desreumaux P, Siepmann J.

J Control Release. 2015 Jan 10;197:121-30. doi: 10.1016/j.jconrel.2014.11.006. Epub 2014 Nov 10.

PMID:
25445696
7.

Anti-stress proteins produced by Bacteroides thetaiotaomicron after nutrient starvation.

Hochart-Behra AC, Drobecq H, Tourret M, Dubreuil L, Behra-Miellet J.

Anaerobe. 2014 Aug;28:18-23. doi: 10.1016/j.anaerobe.2014.04.008. Epub 2014 Apr 28.

PMID:
24785350
8.

Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole.

Dubreuil LJ, Mahieux S, Neut C, Miossec C, Pace J.

Int J Antimicrob Agents. 2012 Jun;39(6):500-4. doi: 10.1016/j.ijantimicag.2012.02.013. Epub 2012 Apr 20.

PMID:
22521766
9.

Chemical extraction versus direct smear for MALDI-TOF mass spectrometry identification of anaerobic bacteria.

Fournier R, Wallet F, Grandbastien B, Dubreuil L, Courcol R, Neut C, Dessein R.

Anaerobe. 2012 Jun;18(3):294-7. doi: 10.1016/j.anaerobe.2012.03.008. Epub 2012 Apr 5.

PMID:
22503696
10.

AIEC colonization and pathogenicity: influence of previous antibiotic treatment and preexisting inflammation.

Drouet M, Vignal C, Singer E, Djouina M, Dubreuil L, Cortot A, Desreumaux P, Neut C.

Inflamm Bowel Dis. 2012 Oct;18(10):1923-31. doi: 10.1002/ibd.22908. Epub 2012 Feb 16.

PMID:
22344932
11.

MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures.

Bille E, Dauphin B, Leto J, Bougnoux ME, Beretti JL, Lotz A, Suarez S, Meyer J, Join-Lambert O, Descamps P, Grall N, Mory F, Dubreuil L, Berche P, Nassif X, Ferroni A.

Clin Microbiol Infect. 2012 Nov;18(11):1117-25. doi: 10.1111/j.1469-0691.2011.03688.x. Epub 2011 Nov 1.

12.

Enzymatically degraded Eurylon 6 HP-PG: ethylcellulose film coatings for colon targeting in inflammatory bowel disease patients.

Karrout Y, Neut C, Siepmann F, Wils D, Ravaux P, Deremaux L, Flament MP, Dubreuil L, Lemdani M, Desreumaux P, Siepmann J.

J Pharm Pharmacol. 2010 Dec;62(12):1676-84. doi: 10.1111/j.2042-7158.2010.01165.x. Epub 2010 Oct 4.

PMID:
21054393
13.

Comparison of vancomycin and teicoplanin trough serum levels in patients with infected orthopedic devices: new data for old therapies.

Lemaire X, Loiez C, Valette M, Migaud H, Dubreuil L, Yazdanpanah Y, Senneville E.

J Infect Chemother. 2011 Jun;17(3):370-4. doi: 10.1007/s10156-010-0176-z. Epub 2010 Nov 5.

PMID:
21053041
14.

Anaerobic bacteria and antibiotics: What kind of unexpected resistance could I find in my laboratory tomorrow?

Dubreuil L, Odou MF.

Anaerobe. 2010 Dec;16(6):555-9. doi: 10.1016/j.anaerobe.2010.10.002. Epub 2010 Oct 28. Review.

PMID:
20971200
15.

Tolerability of prolonged linezolid therapy in bone and joint infection: protective effect of rifampicin on the occurrence of anaemia?

Legout L, Valette M, Dezeque H, Nguyen S, Lemaire X, Loïez C, Caillaux M, Beltrand E, Dubreuil L, Yazdanpanah Y, Migaud H, Senneville E.

J Antimicrob Chemother. 2010 Oct;65(10):2224-30. doi: 10.1093/jac/dkq281. Epub 2010 Jul 29.

PMID:
20675299
16.

[Activity of doripenem against anaerobic bacteria].

Dubreuil L, Neut C, Mahieux S, Muller-Serieys C, Jean-Pierre H, Marchandin H, Soussy CJ, Miara A.

Pathol Biol (Paris). 2011 Apr;59(2):102-7. doi: 10.1016/j.patbio.2010.03.006. Epub 2010 May 26. French.

PMID:
20537808
17.

Impact of infusion method on amikacin serum levels in humans.

Simon N, Décaudin B, Lannoy D, Odou MF, De Broucker M, Barthélémy C, Poret E, Dubreuil L, Odou P.

Pulm Pharmacol Ther. 2010 Aug;23(4):324-6. doi: 10.1016/j.pupt.2010.03.005. Epub 2010 Mar 20.

PMID:
20307680
18.

Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.

Joly-Guillou ML, Kempf M, Cavallo JD, Chomarat M, Dubreuil L, Maugein J, Muller-Serieys C, Roussel-Delvallez M.

BMC Infect Dis. 2010 Mar 18;10:72. doi: 10.1186/1471-2334-10-72.

19.

In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis.

De Backer E, Dubreuil L, Brauman M, Acar J, Vaneechoutte M.

Clin Microbiol Infect. 2010 May;16(5):470-2. doi: 10.1111/j.1469-0691.2009.02852.x. Epub 2009 Jun 22.

20.

Novel polymeric film coatings for colon targeting: Drug release from coated pellets.

Karrout Y, Neut C, Wils D, Siepmann F, Deremaux L, Flament MP, Dubreuil L, Desreumaux P, Siepmann J.

Eur J Pharm Sci. 2009 Jun 28;37(3-4):427-33. doi: 10.1016/j.ejps.2009.03.014. Epub 2009 Apr 5.

PMID:
19491034
21.

Efficacy and tolerance of rifampicin-linezolid compared with rifampicin-cotrimoxazole combinations in prolonged oral therapy for bone and joint infections.

Nguyen S, Pasquet A, Legout L, Beltrand E, Dubreuil L, Migaud H, Yazdanpanah Y, Senneville E.

Clin Microbiol Infect. 2009 Dec;15(12):1163-9. doi: 10.1111/j.1469-0691.2009.02761.x. Epub 2009 May 4.

22.

Colon targeting with bacteria-sensitive films adapted to the disease state.

Karrout Y, Neut C, Wils D, Siepmann F, Deremaux L, Dubreuil L, Desreumaux P, Siepmann J.

Eur J Pharm Biopharm. 2009 Sep;73(1):74-81. doi: 10.1016/j.ejpb.2009.04.003. Epub 2009 May 4.

PMID:
19406234
23.

Clinical and microbiological profiles of community-acquired and nosocomial intra-abdominal infections: results of the French prospective, observational EBIIA study.

Montravers P, Lepape A, Dubreuil L, Gauzit R, Pean Y, Benchimol D, Dupont H.

J Antimicrob Chemother. 2009 Apr;63(4):785-94. doi: 10.1093/jac/dkp005. Epub 2009 Feb 5.

PMID:
19196742
24.

Comparison of the in vitro effects of amoxicillin and ampicillin on the polymorphonuclear neutrophil respiratory burst.

Reynaert ML, Hochart-Behra AC, Behra-Miellet J, Gressier B, Mine L, Dine T, Luyckx M, Dubreuil L, Brunet C.

J Antimicrob Chemother. 2009 Mar;63(3):458-61. doi: 10.1093/jac/dkn545. Epub 2009 Jan 18.

PMID:
19153080
26.

[Pneumonia in a traveller coming back from Asia].

Nguyen S, Baclet N, Huleux T, Pasquet A, Legout L, Dubreuil L, Yazdanpanah Y, Senneville E.

Med Mal Infect. 2008 Dec;38(12):667-70. doi: 10.1016/j.medmal.2008.09.020. Epub 2008 Oct 31. French.

PMID:
18951744
27.

First case of intrafamily transmission of a new MRSA clone with toxic shock syndrome toxin-1.

Lemaire X, Legout L, François C, Lina G, Beltrand E, Senneville E, Dubreuil L, Etienne J, Yazdanpanah Y.

Scand J Infect Dis. 2008;40(8):675-6. doi: 10.1080/00365540701827499.

PMID:
18642160
28.

[Monitoring of antibiotic resistance of gram negative anaerobes].

Singer E, Calvet L, Mory F, Muller C, Chomarat M, Bézian MC, Bland S, Juvenin ME, Drugeon H, Fosse T, Goldstein F, Jaulhac B, Monteil H, Marchandin H, Jean-Pierre H, Dubreuil L.

Med Mal Infect. 2008 May;38(5):256-63. doi: 10.1016/j.medmal.2008.03.007. Epub 2008 May 14. French.

PMID:
18482812
29.

Antioxidative effect of Bacteroides thetaiotaomicron extracts: superoxide dismutase identification.

Hochart-Behra AC, Behra-Miellet J, Sam J, Drobecq H, Gressier B, Luyckx M, Dine T, Brunet C, Dubreuil L.

Anal Bioanal Chem. 2008 May;391(1):415-23. doi: 10.1007/s00216-008-1993-0. Epub 2008 Apr 9.

PMID:
18398604
30.

European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.

Brazier J, Chmelar D, Dubreuil L, Feierl G, Hedberg M, Kalenic S, Könönen E, Lundgren B, Malamou-Ladas H, Nagy E, Sullivan A, Nord CE; ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria.

Int J Antimicrob Agents. 2008 Apr;31(4):316-20. doi: 10.1016/j.ijantimicag.2007.11.006. Epub 2008 Jan 3.

PMID:
18180149
31.

Antimicrobial susceptibilities and clinical sources of Dialister species.

Morio F, Jean-Pierre H, Dubreuil L, Jumas-Bilak E, Calvet L, Mercier G, Devine R, Marchandin H.

Antimicrob Agents Chemother. 2007 Dec;51(12):4498-501. Epub 2007 Oct 8.

32.

[Evaluation of the in vitro activity of two betalactams on the oxidative metabolism of polymorphonuclear neutrophils].

Behra-Miellet J, Darchy A, Gressier B, Dine T, Luyckx M, Brunet C, Dubreuil L.

Pathol Biol (Paris). 2007 Nov;55(8-9):390-7. Epub 2007 Oct 3. French.

PMID:
17916416
33.

In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.

Odou MF, Muller C, Calvet L, Dubreuil L.

J Antimicrob Chemother. 2007 Apr;59(4):646-51. Epub 2007 Mar 9.

PMID:
17350985
34.

Isolation of Dialister pneumosintes isolated from a bacteremia of vaginal origin.

Pierre Lepargneur J, Dubreuil L, Levy J.

Anaerobe. 2006 Oct-Dec;12(5-6):274-5. Epub 2006 Sep 11.

PMID:
16965925
35.

Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey.

Behra-Miellet J, Calvet L, Mory F, Muller C, Chomarat M, Bézian MC, Bland S, Juvenin ME, Fosse T, Goldstein F, Jaulhac B, Dubreuil L.

Anaerobe. 2003 Jun;9(3):105-11.

PMID:
16887696
36.

Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.

Behra-Miellet J, Dubreuil L, Calvet L.

Int J Antimicrob Agents. 2006 Jul;28(1):25-35. Epub 2006 Jun 6.

PMID:
16757152
37.

Improved aero-anaerobe recovery from infected prosthetic joint samples taken from 72 patients and collected intraoperatively in Rosenow's broth.

Senneville E, Savage C, Nallet I, Yazdanpanah Y, Giraud F, Migaud H, Dubreuil L, Courcol R, Mouton Y.

Acta Orthop. 2006 Feb;77(1):120-4.

PMID:
16534711
38.

[Community-acquired acute maxillary sinusitis or rhinosinusitis in adults in France: current management].

Klossek JM, Chidiac C, Serrano E, Gehanno P, Naudé P, Amsellem J, Dubreuil C, Ferrand PA, Jankowski R, May T, Bébéar C, Dubreuil L; Groupe d'Etude des Sinusites Infectieuses II (GESI II).

Presse Med. 2005 Dec 17;34(22 Pt 2):1755-63. Review. French.

PMID:
16395189
39.

Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.

Leroy O, d'Escrivan T, Devos P, Dubreuil L, Kipnis E, Georges H.

Infection. 2005 Jun;33(3):129-35.

PMID:
15940413
40.

In vitro evaluation of faropenem activity against anaerobic bacteria.

Behra-Miellet J, Dubreuil L, Bryskier A.

J Chemother. 2005 Feb;17(1):36-45.

PMID:
15828442
41.

[Management of communal lower respiratory tract infections in the emergency ward: the role of Ketek (telithromycine)].

Dubreuil L, Elkharrat D, Bru JP.

Med Mal Infect. 2004 Jan;34(1):51-6. French. No abstract available.

PMID:
15617327
42.

[Necrotizing soft tissue infections: role of the localization for the antibiotic management].

Wattel F, Mathieu D, Neut C, Dubreuil L, Cesari JF, Favory R.

Bull Acad Natl Med. 2004;188(3):473-86; discussion 486-90. French.

PMID:
15584657
43.

Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.

Senneville E, Legout L, Valette M, Yazdanpanah Y, Giraud F, Beltrand E, Obert G, Dubreuil L, Migaud H, Mouton Y.

J Antimicrob Chemother. 2004 Oct;54(4):798-802. Epub 2004 Aug 25.

PMID:
15329363
44.

A Bacteroides thetaiotamicron porin that could take part in resistance to beta-lactams.

Behra-Miellet J, Calvet L, Dubreuil L.

Int J Antimicrob Agents. 2004 Aug;24(2):135-43.

PMID:
15288312
45.

nimE gene in a metronidazole-susceptible Veillonella sp. strain.

Marchandin H, Jean-Pierre H, Campos J, Dubreuil L, Teyssier C, Jumas-Bilak E.

Antimicrob Agents Chemother. 2004 Aug;48(8):3207-8. No abstract available.

46.

Surveillance of susceptibility patterns in 1297 European and US anaerobic and capnophilic isolates to co-amoxiclav and five other antimicrobial agents.

Koeth LM, Good CE, Appelbaum PC, Goldstein EJ, Rodloff AC, Claros M, Dubreuil LJ.

J Antimicrob Chemother. 2004 Jun;53(6):1039-44. Epub 2004 May 5.

PMID:
15128729
47.

In vitro activity of gatifloxacin, a new fluoroquinolone, against 204 anaerobes compared to seven other compounds.

Dubreuil L, Behra-Miellet J, Neut C, Calvet L.

Clin Microbiol Infect. 2003 Nov;9(11):1133-8.

48.

In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria.

Liebetrau A, Rodloff AC, Behra-Miellet J, Dubreuil L.

Antimicrob Agents Chemother. 2003 Nov;47(11):3667-71.

49.

Activity of linezolid against anaerobic bacteria.

Behra-Miellet J, Calvet L, Dubreuil L.

Int J Antimicrob Agents. 2003 Jul;22(1):28-34.

PMID:
12842325
50.

Beta-lactamase production in Prevotella and in vitro susceptibilities to selected beta-lactam antibiotics [corrected].

Dubreuil L, Behra-Miellet J, Vouillot C, Bland S, Sedallian A, Mory F.

Int J Antimicrob Agents. 2003 Mar;21(3):267-73. Erratum in: Int J Antimicrob Agents. 2003 Aug;22(2):175.

PMID:
12636990

Supplemental Content

Loading ...
Support Center